Ladenburg Thalmann Financial Services’s Neos Therapeutics, Inc NEOS Stock Holding History

Ladenburg Thalmann Financial Services’s Portfolio NEOS Stock Details NEOS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	$1K	Hold	520	–	–	﹤0.01%	5278
2019 Q3	$1K	Hold	520	–	–	﹤0.01%	5212
2019 Q2	$1K	Hold	520	–	–	﹤0.01%	5211
2019 Q1	$1K	Hold	520	–	–	﹤0.01%	5165
2018 Q4	$1K	Hold	520	–	–	﹤0.01%	5151
2018 Q3	$3K	Sell	520 -42	-7%	-$238	﹤0.01%	4823
2018 Q2	$4K	Hold	562	–	–	﹤0.01%	4711
2018 Q1	$4K	Buy	562 +42	+8%	+$401	﹤0.01%	4711
2017 Q4	$5K	Buy	+520	New	+$4.99K	﹤0.01%	4552
2016 Q4	–	Sell	-1,537	Closed	-$10K	–	4995
2016 Q3	$10K	Hold	1,537	–	–	﹤0.01%	3839
2016 Q2	$14K	Hold	1,537	–	–	﹤0.01%	3586
2016 Q1	$17K	Buy	+1,537	New	+$16.2K	﹤0.01%	3384

Other funds holding NEOS

SCM

Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return

NCM

Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return

SFM

Sphera Funds Management Tel Aviv, Israel $630M AUM 108.65% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Russell Investments Group London, United Kingdom $93.1B AUM 28.26% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Ladenburg Thalmann Financial Services's NEOS Position: Q4 2019 in Review

Ladenburg Thalmann Financial Services held its Neos Therapeutics, Inc (NEOS) position steady in Q4 2019 at 520 shares worth $1K. The position accounts for ﹤0.01% of the portfolio, ranked #5278.

Ladenburg Thalmann Financial Services first reported a position in NEOS in Q1 2016 and has held it in 12 quarters since. The position peaked at $17K in Q1 2016. 54 funds tracked by Wall St. Rank hold NEOS as of Q4 2019.

Ladenburg Thalmann Financial Services held 520 shares of Neos Therapeutics, Inc worth $1K as of Q4 2019.
Ladenburg Thalmann Financial Services left its Neos Therapeutics, Inc share count unchanged in Q4 2019.
Neos Therapeutics, Inc made up ﹤0.01% of Ladenburg Thalmann Financial Services's portfolio in Q4 2019, its #5278 holding.
Ladenburg Thalmann Financial Services first reported a position in Neos Therapeutics, Inc in Q1 2016 and has held it in 12 quarters since.
Ladenburg Thalmann Financial Services's Neos Therapeutics, Inc position peaked at $17K in Q1 2016.
54 funds tracked by Wall St. Rank held Neos Therapeutics, Inc as of Q4 2019.

Based on Ladenburg Thalmann Financial Services's 13F filing for Q4 2019, filed 14 Feb 2020.